Monash researchers in consortium granted $1million for lung disease research

A/Prof Christoph Hagemeyer and 

Dr Karen Alt

by Anne Crawford

Associate Professor Christoph Hagemeyer and Dr Karen Alt from the Australian Centre for Blood Diseases (ACBD) together with other researchers from Monash University, the University of Melbourne, the Alfred Hospital and Austin Health have been awarded $1 million* to conduct translational research into idiopathic pulmonary fibrosis (IPF).

IPF causes scar tissue (fibrosis) to build up in the lungs, progressively diminishing lung function and the transportation of oxygen into the bloodstream. The heterogeneous disease is progressive, fatal and incurable.